Panretinal acute multifocal placoid pigment epitheliopathy: a novel posterior uveitis syndrome with HLA-A3 and HLA-C7 association

Journal of Ophthalmic Inflammation and Infection

Table 1 PAMPPE

Patient no./sex/race/age	Eye	Initial visual acuity	Medical history	Duration of activity (weeks)	Treatment	Final visual acuity	HLA typing results
1/F/C/27	R	20/200	Ulcerative colitis, non-specific URI	6	None	20/20	A 2/3
	L	20/60				20/20	B 7/44
	L	20/60				20/20	C 5/7
2/M/C/17	R	20/400	HA, GI, fever, MRI	8	Prednisone, Subtenon's triamcinolone (Bristol-Myers Squibb Company, NY, USA)	20/200	A 1/3
							B 8/35
							C 4/7
3/M/C/16	R	20/400	Non-specific URI	4	Prednisone, PF 1%, oral ciprofloxacin	20/40	A 2/3
3/M/C/16	R	20/400	Non-specific URI	4	Prednisone, PF 1%, oral ciprofloxacin	20/20	B 7/57
	L	20/50					C 6/7

C, Caucasian; HA, headache; GI, gastrointestinal symptoms; MRI, magnetic resonance imaging; URI, upper respiratory tract infection; PF, Pred Forte (Allergan, Inc., CA, USA).